FOR IMMEDIATE RELEASE

September 22, 2006.

Creating diversity and novelty in drug discovery

Zerenex Molecular™ has launched a new collection of over 4000 diverse and unique compounds within the Novel Chemical Entities - NCETM collection.

These rare heterocyclic (small (hetero) cyclic (fused) ring compounds containing one or more chemical handles) including imidazoles, pyridines, pyrazines etc as well as a variety of alycyclic (piperizines, piperidines) and aromatic compounds will continue to assist medicinal and synthetic chemists globally in developing hit generation and hit-to-lead optimization libraries.

Using innovative chemistry, the company has designed, synthesized and acquired a variety of unique building blocks, key to creating diversity and novelty in drug discovery programmes.

Since its inception Zerenex Molecular™ continues to develop and strengthen its global reputation for specializing in the synthesis and supply of unusual small molecule compounds to the pharmaceutical and biotech industries.

About Zerenex Molecular LimitedTM

ZereneX Molecular™ is a dedicated supplier of unique research chemicals (building blocks, screening compounds, natural products and API's) as well as a specialist provider of integrated drug discovery solutions to the life science industry.

ZereneX Molecular™ specialize in:
· Early stage proof-of-concept (POP) projects to validate biological hypotheses
· Validation of screening hits for exploratory medicinal chemistry (hit-to-lead)
· Intermediates for expediting med chemistry SAR campaigns
· Drug candidates for in vivo studies
· Reference agents for bio-profiling
· Reference metabolites
· Building blocks for combinatorial chemistry
· Key intermediates for pharmaceuticals
· Key intermediates for biomaterial and biosensor applications
· Contract research projects

CONTACTS:

ZereneX Molecular Limited 12 Manningham Road Bolton Greater Manchester BL3 5QS, UK tel. +44-1204-527700 web www.zerenex-molecular.com